Latest Headlines

  1. Minaris And Genetix Biotherapeutics Expand Manufacturing Partnership To Support Commercial Supply For LYFGENIA™ (lovotibeglogene autotemcel) 2/24/2026

    Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality biosafety testing provider, and Genetix Biotherapeutics Inc., a commercial-stage biotechnology company dedicated to delivering genetic therapies for patients with severe rare diseases, today announced an expanded manufacturing partnership to increase commercial-scale production of LYFGENIA, Genetix’s FDA-approved, one-time gene therapy for individuals 12 years and older with sickle cell disease.

  2. Minaris Announces Viral Clearance Laboratory Upgrade at Philadelphia Campus 2/24/2026

    Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality biosafety testing provider, today announced an upgrade to its Viral Clearance laboratory capabilities at its Philadelphia campus.

  3. Minaris Joins CIRM Industry Resource Partner Program 2/24/2026

    Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality biosafety testing provider, today announced that it has joined the California Institute for Regenerative Medicine (CIRM) Industry Resource Partner (IRP) Program.

  4. Nucleus Biologics Launches Krakatoa® K500: A Pod-Based, On-Demand Media And Buffer Manufacturing System Transforming Scale Bioproduction 2/13/2026

    Nucleus Biologics announces the launch of Krakatoa® K500, the first bioreactor-scale, pod-based media and buffer manufacturing system designed to deliver sterile solutions on demand and at point-of-use.

  5. JHS CEO Chris Preti Receives 2026 Person Of Influence Award 2/12/2026

    Spokane, WA. - The Spokane Journal of Business named Chris Preti, CEO of Jubilant HollisterStier (JHS), as one of its 2026 People of Influence.

  6. AGC Biologics Seattle Site Now Certified To Manufacture Biologics For Largest Pharmaceutical Market In South America 2/5/2026

    AGC Biologics’ Seattle site earned Anvisa GMP certification, enabling biologics and biosimilars produced there to enter Brazil’s expanding pharmaceutical market and strengthening the facility’s global regulatory track record.

  7. Eurofins CDMO Alphora Joins International Consortium Project To Advance Next Generation ADC Expression Platform 2/5/2026

    As part of this initiative, Eurofins CDMO Alphora (Canada) is collaborating with Daresbury Proteins Ltd. (UK) to contribute its development and manufacturing expertise to the NextGen ADC Platform: Engineering High Yielding Expression Vectors and Peptide Linker Tags for Advanced ADC Production initiative.

  8. Axion BioSystems Acquires High-Throughput, High-Density CMOS MEA Technology From CytoTronics 2/4/2026

    Next-generation CMOS MEA chip technology acquired by Axion BioSystems integrates over 13 million nanoscale multimodal electrode-based sensors distributed across industry-standard 96- or 384-well microplates, enabling high-throughput, single-cell–level functional screening for disease research and drug discovery.

  9. Kindeva Announces Leadership Transition To Drive Strategic Growth 1/16/2026

    Kindeva, a global contract development and manufacturing organization (CDMO) and drug delivery innovator, today announced a series of planned leadership transitions designed to position the company for accelerating growth in its core businesses focused on parenteral and inhaled drug delivery. 

  10. Cellares Expands Global Footprint With New European IDMO Smart Factory In Leiden 1/16/2026

    Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced it has secured a site and signed a long-term lease for a new IDMO Smart Factory at Leiden Bio Science Park (LBSP) with Dura Vermeer Commercieel Vastgoed. The facility will serve as Cellares’ European headquarters and expand the company’s global manufacturing network with dedicated regional capacity.